Introduction Urothelial carcinoma represents the most common form of bladder cancer and often presents at an advanced stage, where treatment outcomes remain poor despite initial responses to platinum-based chemotherapy (1). Historically, patients achieving disease control after chemotherapy had limited maintenance options, with observation being th